Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jul 03, 2024 11:42pm
232 Views
Post# 36117579

RE:Today's TLD1433 Shout Out

RE:Today's TLD1433 Shout Out

Thanks for the TLD 1433 shout out...This compound should finally put an end to that 30+ year legacy of Photofrin.  Head-to-head, it's night & day between these compounds.  It's actually a shame (& scientifically embarrassing) that after so many years, Photofrin is "still" being broadly used as the primary go-to photosensitizer for ongoing/new PDT-based clinical trials...probably 50+ trials.  

Considering both the myriad levels of validation Theralase has achieved so far for TLD 1433 & the high level of unmet need in this field, I can't see how the FDA doesn't give the green light if results contiune to pan out as expected.  A green light to TLD 1433 is a potential cure to cancer...my new company slogan ; ) 

<< Previous
Bullboard Posts
Next >>